「monitoring」の検索結果

Suggests CSII with good adherence to monitoring and dosing for adults with type 2 diabetes mellitus who have poor glycemic control despite intensive insulin therapy, oral agents, other injectable therapy, and lifestyle modifications. Trigger phrases include 'T2DM on multiple injectables still uncontrolled' and 'Consider pump for insulin-requiring T2DM failing other therapies'.

日本語の概要は準備中です。原文の説明を表示しています。

Reassesses annually the patient’s use of self-monitoring blood glucose to calibrate the CGM system. Triggered by ‘Yearly calibration practice review’ or ‘Annual check of SMBG calibration adherence’.

日本語の概要は準備中です。原文の説明を表示しています。

Suggests that adults with type 1 or type 2 diabetes using continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) receive education, training, and ongoing support to achieve and maintain individualized glycemic goals. Trigger phrases include: 'Patient on pump plus CGM, arrange education' and 'Ensure CSII+CGM users get training and support'.

日本語の概要は準備中です。原文の説明を表示しています。

This skill guides postoperative management after Cushing's syndrome surgery by classifying patients into hypocortisolism, hypercortisolism, or eucortisolism based on serum cortisol levels. Use when postoperative cortisol is <5 µg/dL (hypocortisolism), >20 µg/dL (hypercortisolism), or 5-20 µg/dL (eucortisolism) to direct glucocorticoid replacement, further treatment, or monitoring.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends educating patients and families about the clinical features of remission in Cushing's syndrome when a patient achieves biochemical remission after treatment. Use when a CS patient has postoperative normal cortisol levels, reports symptom improvement, and requires guidance on long-term expectations and monitoring for recurrence.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends measuring serum sodium several times during the first 5–14 days after transsphenoidal surgery to detect and manage electrolyte disturbances such as postoperative hyponatremia and diabetes insipidus. Use when managing a post-TSS Cushing’s syndrome patient in the early recovery phase; triggers include postoperative day 5–10 hyponatremia, polyuria, fluid intake‑output imbalance, or suspected diabetes insipidus.

日本語の概要は準備中です。原文の説明を表示しています。

Provides evidence-based guidelines for preoperative optimization and postoperative monitoring in patients with primary aldosteronism undergoing adrenalectomy. Triggers include when planning surgery or starting treatment and asking 'What perioperative care is needed?' or managing complications such as resistant hypertension, hypokalemia, or suspected cortisol co-secretion.

日本語の概要は準備中です。原文の説明を表示しています。

Suggests monitoring DHEA replacement in women with primary adrenal insufficiency (PAI) by measuring morning serum DHEAS levels before the daily dose, targeting the mid‑normal range. Consider when evaluating low libido, depressive symptoms, or low energy despite optimized glucocorticoid and mineralocorticoid replacement.

日本語の概要は準備中です。原文の説明を表示しています。

This skill outlines monitoring glucocorticoid replacement in children with primary adrenal insufficiency (PAI) using clinical assessment of growth velocity, weight, blood pressure, and energy levels. Trigger when evaluating a child with PAI for adequacy of glucocorticoid therapy during routine follow-up.

日本語の概要は準備中です。原文の説明を表示しています。

This skill outlines monitoring of mineralocorticoid replacement in primary adrenal insufficiency, focusing on clinical assessment of salt craving, postural hypotension, or edema alongside serum electrolyte measurements. It is initiated when evaluating patients on fludrocortisone therapy to ensure adequate dosing and avoid over- or under-replacement.

日本語の概要は準備中です。原文の説明を表示しています。

Guides individualised HbA1c target-setting and identifies the correct intensification trigger for adults with type 2 diabetes using the NICE NG28 (2026) framework, covering standard targets, hypoglycaemia-risk adjustment, indications for target relaxation, and appropriate monitoring frequency.

日本語の概要は準備中です。原文の説明を表示しています。

The Endocrine Society guideline recommends against routine hormonal monitoring of glucocorticoid replacement in primary adrenal insufficiency and advises adjusting therapy solely based on clinical response. Use when evaluating glucocorticoid dose adequacy, such as when patients report fatigue, weight loss, hypotension, or signs of Cushingoid over-replacement.

日本語の概要は準備中です。原文の説明を表示しています。

Suggests testing HPA axis functionality before and after starting GH replacement in patients not receiving glucocorticoid replacement with apparently normal pituitary-adrenal function. Triggers include initiating GH replacement in a GHD patient who is not on glucocorticoids and has normal adrenal function.

日本語の概要は準備中です。原文の説明を表示しています。

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

Select the right pharmacologic agent for a child aged 12+ with obesity using the CMAJ 2025 guideline — choosing between GLP-1 receptor agonists, metformin, or orlistat with monitoring guidance. Trigger when a clinician asks which medication to use for pediatric obesity, whether to start semaglutide or metformin in a child, or how to manage obesity pharmacologically in adolescents.

日本語の概要は準備中です。原文の説明を表示しています。

Build anomaly detection applications with Azure AI Anomaly Detector SDK for Java. Use when implementing univariate/multivariate anomaly detection, time-series analysis, or AI-powered monitoring.

日本語の概要は準備中です。原文の説明を表示しています。

Scrape reviews, ratings, and brand mentions from multiple platforms using Apify Actors.

日本語の概要は準備中です。原文の説明を表示しています。

Testing and benchmarking LLM agents including behavioral testing, capability assessment, reliability metrics, and production monitoring—where even top agents achieve less than 50% on real-world benchmarks

日本語の概要は準備中です。原文の説明を表示しています。

Use for read-first Amazon Sponsored Products optimization, product-aware growth, preflight readiness, and post-change monitoring reviews that can run standalone from static exports or use Rocketcart MCP as an optional Amazon Ads plus product-intelligence layer. Guides Codex to inspect Rocketcart profiles, live SP campaigns, product ads/ASIN context, category rank/BSR movement, competitor signals, product readiness, budget and targeting drift, snapshots/changelogs, and proposed approval-gated action rows without executing writes by default.

日本語の概要は準備中です。原文の説明を表示しています。

Plan and implement infrastructure, CI/CD, container, deployment, observability, and operational configuration changes with least privilege, staged validation, and rollback awareness. Use for pipelines, infrastructure as code, Kubernetes, containers, release automation, monitoring, and production-readiness work; do not use to perform destructive production actions without explicit authorization.

日本語の概要は準備中です。原文の説明を表示しています。

Prepares production launches. Use when preparing to deploy to production. Use when you need a pre-launch checklist, when setting up monitoring, when planning a staged rollout, or when you need a rollback strategy.

日本語の概要は準備中です。原文の説明を表示しています。

Watches an open pull request's CI until green and fixes failing checks. TRIGGER when: the user wants to watch a pull request's CI, babysit a PR until it goes green, or fix failing CI checks on an open PR. DO NOT TRIGGER when: opening the PR in the first place → pr; rebasing the branch onto its base → rebase.

日本語の概要は準備中です。原文の説明を表示しています。

Rebases a feature branch onto its latest base, resolving conflicts while preserving the intent of local changes, optionally force-pushing and watching CI afterward. TRIGGER when: the user wants to rebase a feature branch, update a branch against its base, or replay local work on top of the latest upstream. DO NOT TRIGGER when: merging a release branch into dev → merging-branches; only watching CI on an already-open PR → monitoring-pull-requests.

日本語の概要は準備中です。原文の説明を表示しています。

Opens a pull request, publishing the current branch as a PR. TRIGGER when: the user wants to open a pull request, publish the current branch as a PR, or take the current work through to an open PR. DO NOT TRIGGER when: only committing changes → commit; babysitting CI after the PR is already open → monitoring-pull-requests.

日本語の概要は準備中です。原文の説明を表示しています。